A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Stopped Sponsor decided not to initiate the study for alternate commercial strategy

Conditions

• Advanced Biliary Tract Cancer

Interventions

• DRUG: SPARC1507
• DRUG: Reference1507

Sponsor

Sun Pharma Advanced Research Company Limited